Shenzhen Salubris Pharmaceuticals Co., Ltd. approved Cash dividend of CNY 4.00000000 per 10 shares (tax included) for 2021 its Annual General Meeting of 2021 on 18 April 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.97 CNY | -1.90% | +4.06% | -8.24% |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.24% | 4.6B | |
+17.97% | 42.77B | |
+20.21% | 22.23B | |
+13.12% | 14.44B | |
+12.19% | 13.05B | |
+35.45% | 11.59B | |
-8.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.29% | 4.97B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Shenzhen Salubris Pharmaceuticals Co., Ltd. Approves Cash Dividend for 2021